SYFA_HUMAN - dbPTM
SYFA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SYFA_HUMAN
UniProt AC Q9Y285
Protein Name Phenylalanine--tRNA ligase alpha subunit
Gene Name FARSA
Organism Homo sapiens (Human).
Sequence Length 508
Subcellular Localization Cytoplasm .
Protein Description
Protein Sequence MADGQVAELLLRRLEASDGGLDSAELAAELGMEHQAVVGAVKSLQALGEVIEAELRSTKHWELTAEGEEIAREGSHEARVFRSIPPEGLAQSELMRLPSGKVGFSKAMSNKWIRVDKSAADGPRVFRVVDSMEDEVQRRLQLVRGGQAEKLGEKERSELRKRKLLAEVTLKTYWVSKGSAFSTSISKQETELSPEMISSGSWRDRPFKPYNFLAHGVLPDSGHLHPLLKVRSQFRQIFLEMGFTEMPTDNFIESSFWNFDALFQPQQHPARDQHDTFFLRDPAEALQLPMDYVQRVKRTHSQGGYGSQGYKYNWKLDEARKNLLRTHTTSASARALYRLAQKKPFTPVKYFSIDRVFRNETLDATHLAEFHQIEGVVADHGLTLGHLMGVLREFFTKLGITQLRFKPAYNPYTEPSMEVFSYHQGLKKWVEVGNSGVFRPEMLLPMGLPENVSVIAWGLSLERPTMIKYGINNIRELVGHKVNLQMVYDSPLCRLDAEPRPPPTQEAA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MADGQVAEL
------CCCHHHHHH
29.6419413330
12MethylationQVAELLLRRLEASDG
HHHHHHHHHHHHCCC
40.90-
32SulfoxidationELAAELGMEHQAVVG
HHHHHHCCHHHHHHH
6.9430846556
43PhosphorylationAVVGAVKSLQALGEV
HHHHHHHHHHHHHHH
21.0821712546
59UbiquitinationEAELRSTKHWELTAE
HHHHHCCCCEEEEEC
48.2221890473
59UbiquitinationEAELRSTKHWELTAE
HHHHHCCCCEEEEEC
48.22-
59AcetylationEAELRSTKHWELTAE
HHHHHCCCCEEEEEC
48.2225953088
99PhosphorylationSELMRLPSGKVGFSK
HHHHCCCCCCCCCCH
56.7024719451
101UbiquitinationLMRLPSGKVGFSKAM
HHCCCCCCCCCCHHH
43.45-
101UbiquitinationLMRLPSGKVGFSKAM
HHCCCCCCCCCCHHH
43.45-
101MalonylationLMRLPSGKVGFSKAM
HHCCCCCCCCCCHHH
43.4526320211
101AcetylationLMRLPSGKVGFSKAM
HHCCCCCCCCCCHHH
43.4525953088
106UbiquitinationSGKVGFSKAMSNKWI
CCCCCCCHHHCCCEE
45.94-
106UbiquitinationSGKVGFSKAMSNKWI
CCCCCCCHHHCCCEE
45.94-
106MalonylationSGKVGFSKAMSNKWI
CCCCCCCHHHCCCEE
45.9426320211
106AcetylationSGKVGFSKAMSNKWI
CCCCCCCHHHCCCEE
45.9425953088
109PhosphorylationVGFSKAMSNKWIRVD
CCCCHHHCCCEEEEE
39.8728857561
111UbiquitinationFSKAMSNKWIRVDKS
CCHHHCCCEEEEECC
36.37-
111UbiquitinationFSKAMSNKWIRVDKS
CCHHHCCCEEEEECC
36.37-
111AcetylationFSKAMSNKWIRVDKS
CCHHHCCCEEEEECC
36.3725953088
117AcetylationNKWIRVDKSAADGPR
CCEEEEECCCCCCCC
38.8523749302
117UbiquitinationNKWIRVDKSAADGPR
CCEEEEECCCCCCCC
38.8521890473
117AcetylationNKWIRVDKSAADGPR
CCEEEEECCCCCCCC
38.85-
117UbiquitinationNKWIRVDKSAADGPR
CCEEEEECCCCCCCC
38.85-
1172-HydroxyisobutyrylationNKWIRVDKSAADGPR
CCEEEEECCCCCCCC
38.85-
118PhosphorylationKWIRVDKSAADGPRV
CEEEEECCCCCCCCE
24.99-
124MethylationKSAADGPRVFRVVDS
CCCCCCCCEEEEECC
45.82-
132SulfoxidationVFRVVDSMEDEVQRR
EEEEECCCHHHHHHH
6.9621406390
144MethylationQRRLQLVRGGQAEKL
HHHHHHHHCCHHHHH
52.71-
150UbiquitinationVRGGQAEKLGEKERS
HHCCHHHHHCHHHHH
65.8821890473
150UbiquitinationVRGGQAEKLGEKERS
HHCCHHHHHCHHHHH
65.88-
150AcetylationVRGGQAEKLGEKERS
HHCCHHHHHCHHHHH
65.8825953088
154UbiquitinationQAEKLGEKERSELRK
HHHHHCHHHHHHHHH
57.54-
154UbiquitinationQAEKLGEKERSELRK
HHHHHCHHHHHHHHH
57.54-
157PhosphorylationKLGEKERSELRKRKL
HHCHHHHHHHHHHHH
41.9128634120
163UbiquitinationRSELRKRKLLAEVTL
HHHHHHHHHHHEEEE
51.38-
177UbiquitinationLKTYWVSKGSAFSTS
EEEEEEECCCCCCCC
47.4621890473
177UbiquitinationLKTYWVSKGSAFSTS
EEEEEEECCCCCCCC
47.46-
177AcetylationLKTYWVSKGSAFSTS
EEEEEEECCCCCCCC
47.4626051181
179PhosphorylationTYWVSKGSAFSTSIS
EEEEECCCCCCCCCC
29.8527080861
182PhosphorylationVSKGSAFSTSISKQE
EECCCCCCCCCCHHC
22.4423090842
183PhosphorylationSKGSAFSTSISKQET
ECCCCCCCCCCHHCC
24.5122199227
184PhosphorylationKGSAFSTSISKQETE
CCCCCCCCCCHHCCC
24.5429507054
186PhosphorylationSAFSTSISKQETELS
CCCCCCCCHHCCCCC
28.2229514088
187UbiquitinationAFSTSISKQETELSP
CCCCCCCHHCCCCCH
50.9421890473
187AcetylationAFSTSISKQETELSP
CCCCCCCHHCCCCCH
50.9426051181
190PhosphorylationTSISKQETELSPEMI
CCCCHHCCCCCHHHH
39.4730108239
193PhosphorylationSKQETELSPEMISSG
CHHCCCCCHHHHHCC
16.7525159151
198PhosphorylationELSPEMISSGSWRDR
CCCHHHHHCCCCCCC
27.6030108239
198UbiquitinationELSPEMISSGSWRDR
CCCHHHHHCCCCCCC
27.60-
199PhosphorylationLSPEMISSGSWRDRP
CCHHHHHCCCCCCCC
26.3929396449
201PhosphorylationPEMISSGSWRDRPFK
HHHHHCCCCCCCCCC
22.3829396449
208UbiquitinationSWRDRPFKPYNFLAH
CCCCCCCCCCCEEEC
49.64-
208AcetylationSWRDRPFKPYNFLAH
CCCCCCCCCCCEEEC
49.6426051181
210PhosphorylationRDRPFKPYNFLAHGV
CCCCCCCCCEEECEE
21.0928796482
244PhosphorylationIFLEMGFTEMPTDNF
HHHHCCCCCCCCCCC
26.1626074081
248PhosphorylationMGFTEMPTDNFIESS
CCCCCCCCCCCHHHC
42.1226074081
254PhosphorylationPTDNFIESSFWNFDA
CCCCCHHHCCCCHHH
26.4726074081
255PhosphorylationTDNFIESSFWNFDAL
CCCCHHHCCCCHHHC
22.8426074081
280UbiquitinationQHDTFFLRDPAEALQ
CCCCCEECCHHHHHC
42.59-
284UbiquitinationFFLRDPAEALQLPMD
CEECCHHHHHCCCHH
56.1321890473
292PhosphorylationALQLPMDYVQRVKRT
HHCCCHHHHHHHHHH
7.70-
292NitrationALQLPMDYVQRVKRT
HHCCCHHHHHHHHHH
7.70-
297AcetylationMDYVQRVKRTHSQGG
HHHHHHHHHHHHCCC
54.497663211
299PhosphorylationYVQRVKRTHSQGGYG
HHHHHHHHHHCCCCC
21.8425159151
301PhosphorylationQRVKRTHSQGGYGSQ
HHHHHHHHCCCCCCC
29.8823401153
305PhosphorylationRTHSQGGYGSQGYKY
HHHHCCCCCCCCCCE
22.0423403867
307PhosphorylationHSQGGYGSQGYKYNW
HHCCCCCCCCCCEEC
16.3728152594
310PhosphorylationGGYGSQGYKYNWKLD
CCCCCCCCCEECCHH
11.5828152594
311AcetylationGYGSQGYKYNWKLDE
CCCCCCCCEECCHHH
38.6419608861
311SumoylationGYGSQGYKYNWKLDE
CCCCCCCCEECCHHH
38.64-
311UbiquitinationGYGSQGYKYNWKLDE
CCCCCCCCEECCHHH
38.6421906983
311SumoylationGYGSQGYKYNWKLDE
CCCCCCCCEECCHHH
38.6419608861
311UbiquitinationGYGSQGYKYNWKLDE
CCCCCCCCEECCHHH
38.64-
312UbiquitinationYGSQGYKYNWKLDEA
CCCCCCCEECCHHHH
20.12-
315UbiquitinationQGYKYNWKLDEARKN
CCCCEECCHHHHHHH
42.2821890473
315AcetylationQGYKYNWKLDEARKN
CCCCEECCHHHHHHH
42.2825953088
318UbiquitinationKYNWKLDEARKNLLR
CEECCHHHHHHHHHH
61.8921890473
326PhosphorylationARKNLLRTHTTSASA
HHHHHHHHHCCCHHH
24.4427080861
328PhosphorylationKNLLRTHTTSASARA
HHHHHHHCCCHHHHH
23.1027080861
342UbiquitinationALYRLAQKKPFTPVK
HHHHHHHCCCCCCCE
57.73-
343UbiquitinationLYRLAQKKPFTPVKY
HHHHHHCCCCCCCEE
33.0321890473
3432-HydroxyisobutyrylationLYRLAQKKPFTPVKY
HHHHHHCCCCCCCEE
33.03-
346PhosphorylationLAQKKPFTPVKYFSI
HHHCCCCCCCEEEEE
35.3821712546
349AcetylationKKPFTPVKYFSIDRV
CCCCCCCEEEEEEEE
41.6188315
349UbiquitinationKKPFTPVKYFSIDRV
CCCCCCCEEEEEEEE
41.6121890473
355MethylationVKYFSIDRVFRNETL
CEEEEEEEEECCCCC
28.01-
366UbiquitinationNETLDATHLAEFHQI
CCCCCHHHHHHHHCC
25.43-
375UbiquitinationAEFHQIEGVVADHGL
HHHHCCCEEEECCCC
22.3421890473
396UbiquitinationGVLREFFTKLGITQL
HHHHHHHHHHCCEEC
30.58-
397UbiquitinationVLREFFTKLGITQLR
HHHHHHHHHCCEECE
39.2921890473
397UbiquitinationVLREFFTKLGITQLR
HHHHHHHHHCCEECE
39.29-
397AcetylationVLREFFTKLGITQLR
HHHHHHHHHCCEECE
39.2926051181
406UbiquitinationGITQLRFKPAYNPYT
CCEECEEECCCCCCC
23.4621890473
406AcetylationGITQLRFKPAYNPYT
CCEECEEECCCCCCC
23.4626051181
412PhosphorylationFKPAYNPYTEPSMEV
EECCCCCCCCCCCEE
21.7929496907
427UbiquitinationFSYHQGLKKWVEVGN
EEECCCHHHHHHCCC
51.95-
437UbiquitinationVEVGNSGVFRPEMLL
HHCCCCCCCCHHHHC
3.5521890473
450UbiquitinationLLPMGLPENVSVIAW
HCCCCCCCCEEEEEE
75.2621890473
468UbiquitinationLERPTMIKYGINNIR
CCCCHHHHHCCCCHH
26.9721890473
469PhosphorylationERPTMIKYGINNIRE
CCCHHHHHCCCCHHH
16.5928152594
481UbiquitinationIRELVGHKVNLQMVY
HHHHHCCCCEEEEEE
27.2221890473
481AcetylationIRELVGHKVNLQMVY
HHHHHCCCCEEEEEE
27.2225953088
486SulfoxidationGHKVNLQMVYDSPLC
CCCCEEEEEECCCCC
3.2121406390
488PhosphorylationKVNLQMVYDSPLCRL
CCEEEEEECCCCCCC
12.8321945579
490PhosphorylationNLQMVYDSPLCRLDA
EEEEEECCCCCCCCC
11.3321945579
493S-palmitoylationMVYDSPLCRLDAEPR
EEECCCCCCCCCCCC
4.6329575903
504PhosphorylationAEPRPPPTQEAA---
CCCCCCCCCCCC---
44.8321815630

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
301SPhosphorylationKinaseATRQ13535
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SYFA_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SYFA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ECSIT_HUMANECSITphysical
21163940
SYFB_HUMANFARSBphysical
22939629
TDGF1_HUMANTDGF1physical
21988832
GORAB_HUMANGORABphysical
21988832
RLA0_HUMANRPLP0physical
22863883
ABI3_HUMANABI3physical
25416956
SYFB_HUMANFARSBphysical
26186194
TCPW_HUMANCCT6Bphysical
26186194
SYFB_HUMANFARSBphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00120L-Phenylalanine
Regulatory Network of SYFA_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-311, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193, AND MASSSPECTROMETRY.

TOP